Yen-Huei Lin

Yen-Huei Lin has extensive work experience in the pharmaceutical and biotech industry. From 2001 to 2008, they worked at Wyeth as a Senior Research Scientist and later as a Principal Research Scientist, where they led teams in designing stable formulations for novel vaccines and evaluated projects for strategic decision-making. From 2008 to 2012, they worked at Human Genome Sciences as a Sr. Scientist & Lean Six Sigma Green Belt, leading continuous improvement projects and reducing cycle time and waste. From 2012 to 2015, they worked at Teva Biopharmaceuticals USA as a Principal Scientist, managing drug product development and leading container closure system development. From 2015 to 2019, they worked at NOVAVAX INC as a Senior Director, overseeing formulation and drug product development, as well as collaborating with various committees and teams. Since 2019, they have been working at Neuraly, Inc. as Vice President of Technology Development and Manufacturing, where they have established CMC operations and built a network for product development and supply chains.

Yen-Huei Lin holds a Ph.D. in Micrology and Molecular Genetics from Rutgers University. Prior to that, they completed a Bachelor of Science degree in Plant Pathology and Entomology at National Taiwan University. No specific start or end years were provided for either of these educational experiences.